Copyright (c) 2026 Basappa Basappa, Dileep Nagaraju, Mamatha S Kempasiddegowda, Mahesha Kumaraswamy, Bhoomika B Ravi, Monisha Yadav H S, Toreshettahally R Swaroop, Santosh L Goankar

This work is licensed under a Creative Commons Attribution 4.0 International License.
Piperazine-Pyrrolidone Acyl Hydrazide Hybrids as New Anticancer Agents against Breast Cancer
Corresponding Author(s) : Basappa Basappa
Asian Journal of Chemistry,
Vol. 38 No. 8 (2026): Vol 38, Issue 8 (2026)
Abstract
Present work describes the development and evaluation of novel piperazine–pyrrolidone acyl hydrazide hybrids as potential anticancer agents for breast cancer treatment. The cytotoxic activities of these compounds were determined against human breast cancer cell lines (MCF-7) by alamar blue assay. A compound 1-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)-5-oxopyrrolidine-3-carbohydrazide (7b) showed the highest cytotoxicity with IC50 value of 1.46 µM. The lead candidate exhibited superior activity compared to the standard drug tamoxifen (1.75 µM) and was approximately two-fold less potent than doxorubicin (0.73 µM). A structure–activity relationship (SAR) analysis was carried out to understand the effect of structural modifications on anticancer activity. The findings suggest that the lead molecule induces apoptosis in cancer cells by inhibiting the interaction between BCL-XL and BAD, a mechanism supported by in silico studies.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- M. Faizan, R. Kumar, A. Mazumder, N. Salahuddin, N. Kukreti, A. Kumar and M.V.N.L. Chaitanya, Chem. Biol. Drug Des., 103, e14537 (2024); https://doi.org/10.1111/cbdd.14537
- S. Singh, R. Kumar, S. Tripathi, A. Salahuddin, A. Mazumder and N. Singh, Chem. Biol. Drug Des., 105, e70077 (2025); https://doi.org/10.1111/cbdd.70077
- A.A. Bhat, I. Singh, N. Tandon and R. Tandon, Eur. J. Med. Chem., 246, 114954 (2023); https://doi.org/10.1016/j.ejmech.2022.114954
- Y. Biliz, B. Hasdemir, H. Başpınar Küçük, M. Zaim, A.M. Şentürk, A. Müdüroğlu Kırmızıbekmez and İ. Kara, ACS Omega, 8, 20073 (2023); https://doi.org/10.1021/acsomega.3c02361
- A. Ten, R. Koizhaiganova, D. Bissenbay, B. Tursynova, Z. Zhaxibayeva and V. Yu, ChemistryOpen, 15, e202500366 (2026); https://doi.org/10.1002/open.202500366
- A.-L. Mathieu, O. Sperandio, V. Pottiez, S. Balzarin, A. Herlédan, J. O. Elkaïm, M.-L. Fogeron, C. Piveteau, S. Dassonneville, B. Deprez, B.O. Villoutreix, N. Bonnefoy and F. Leroux, SLAS Discov., 19, 1035 (2014); https://doi.org/10.1177/1087057114534070
- N. Rajeev, T.R. Swaroop, S.M. Anil, K.R. Kiran, K.S. Rangappa and M.P. Sadashiva, J. Chem. Sci., 130, 150 (2018); https://doi.org/10.1007/s12039-018-1540-2
- T.R. Swaroop, Z.-Q. Wang, Q.Y. Li and H.-S. Wang, J. Electrochem. Soc., 167, 046504 (2020); https://doi.org/10.1149/1945-7111/ab72ed
- H.B. Harsha, S. Rangappa, H.D. Preetham, T.R. Swaroop, M. Gilandoust, K.S. Rakesh and K.S. Rangappa, ChemistrySelect, 3, 5228 (2018); https://doi.org/10.1002/slct.201800053
- S.D. Preethi, K.S. Balaji, D.S. Prasanna, V.H. Kameshwar, J. Shankar, T.R. Swaroop, L. Siddalingaiah and K.S. Rangappa, Anticancer Agents Med. Chem., 17, 1931 (2017); https://doi.org/10.2174/1871521409666170412120837
- S.M. Abdel-Wahab, Z.K. Abdelsamii, H.A. Abdel-Fattah, A.S. El-Etrawy, L.N. Dawe, T.R. Swaroop and P.E. Georghiou, ChemistrySelect, 3, 8106 (2018); https://doi.org/10.1002/slct.201801151
- R. Roopashree, C.D. Mohan, T.R. Swaroop, S. Jagadish and K.S. Rangappa, Asian J. Pharm. Clin. Res., 7, 309 (2014).
- Y.H. Lee, S. Lee, J. Sim, E. S. Jo, J.-K. Jung, S. Hyun and J.-H. Kwak, Bull. Korean Chem. Soc., 47, 333 (2026); https://doi.org/10.1002/bkcs.70101
- H.M. Poh, Y.S. Chiou, Q.Y. Chong, R.M. Chen, K.S. Rangappa, L. Ma, T. Zhu, A.P. Kumar, V. Pandey, S. Basappa, S.-C. Lee and P. Lobie, Cancers, 11, 1528 (2019); https://doi.org/10.3390/cancers11101528
- M. Gilandoust, K.B. Harsha, C.D. Mohan, A.R. Raquib, S. Rangappa, V. Pandey, P.E. Lobie, Basappa and K.S. Rangappa, Bioorg. Med. Chem. Lett., 28, 2314 (2018); https://doi.org/10.1016/j.bmcl.2018.05.020
- Q.Y. Chong, M.L. You, V. Pandey, A. Banerjee, Y.J. Chen, H.M. Poh, M. Zhang, L. Ma, T. Zhu, S. Basappa, L. Liu and P.E. Lobie, Oncotarget, 8, 74188 (2017); https://doi.org/10.18632/oncotarget.18431
- D.S. Goodsell, M.F. Sanner, A.J. Olson and S. Forli, Protein Sci., 30, 31 (2021); https://doi.org/10.1002/pro.3934
- M.D. Hanwell, D.E. Curtis, D.C. Lonie, T. Vandermeersch, E. Zurek and G.R. Hutchison, J. Cheminform., 4, 17 (2012); https://doi.org/10.1186/1758-2946-4-17
- BIOVIA, Dassault Systèmes, Discovery Studio Visualizer, version 21.1.0.20298, Dassault Systèmes: San Diego, CA, USA (2020).
- E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng and T.E. Ferrin, J. Comput. Chem., 25, 1605 (2004); https://doi.org/10.1002/jcc.20084
References
M. Faizan, R. Kumar, A. Mazumder, N. Salahuddin, N. Kukreti, A. Kumar and M.V.N.L. Chaitanya, Chem. Biol. Drug Des., 103, e14537 (2024); https://doi.org/10.1111/cbdd.14537
S. Singh, R. Kumar, S. Tripathi, A. Salahuddin, A. Mazumder and N. Singh, Chem. Biol. Drug Des., 105, e70077 (2025); https://doi.org/10.1111/cbdd.70077
A.A. Bhat, I. Singh, N. Tandon and R. Tandon, Eur. J. Med. Chem., 246, 114954 (2023); https://doi.org/10.1016/j.ejmech.2022.114954
Y. Biliz, B. Hasdemir, H. Başpınar Küçük, M. Zaim, A.M. Şentürk, A. Müdüroğlu Kırmızıbekmez and İ. Kara, ACS Omega, 8, 20073 (2023); https://doi.org/10.1021/acsomega.3c02361
A. Ten, R. Koizhaiganova, D. Bissenbay, B. Tursynova, Z. Zhaxibayeva and V. Yu, ChemistryOpen, 15, e202500366 (2026); https://doi.org/10.1002/open.202500366
A.-L. Mathieu, O. Sperandio, V. Pottiez, S. Balzarin, A. Herlédan, J. O. Elkaïm, M.-L. Fogeron, C. Piveteau, S. Dassonneville, B. Deprez, B.O. Villoutreix, N. Bonnefoy and F. Leroux, SLAS Discov., 19, 1035 (2014); https://doi.org/10.1177/1087057114534070
N. Rajeev, T.R. Swaroop, S.M. Anil, K.R. Kiran, K.S. Rangappa and M.P. Sadashiva, J. Chem. Sci., 130, 150 (2018); https://doi.org/10.1007/s12039-018-1540-2
T.R. Swaroop, Z.-Q. Wang, Q.Y. Li and H.-S. Wang, J. Electrochem. Soc., 167, 046504 (2020); https://doi.org/10.1149/1945-7111/ab72ed
H.B. Harsha, S. Rangappa, H.D. Preetham, T.R. Swaroop, M. Gilandoust, K.S. Rakesh and K.S. Rangappa, ChemistrySelect, 3, 5228 (2018); https://doi.org/10.1002/slct.201800053
S.D. Preethi, K.S. Balaji, D.S. Prasanna, V.H. Kameshwar, J. Shankar, T.R. Swaroop, L. Siddalingaiah and K.S. Rangappa, Anticancer Agents Med. Chem., 17, 1931 (2017); https://doi.org/10.2174/1871521409666170412120837
S.M. Abdel-Wahab, Z.K. Abdelsamii, H.A. Abdel-Fattah, A.S. El-Etrawy, L.N. Dawe, T.R. Swaroop and P.E. Georghiou, ChemistrySelect, 3, 8106 (2018); https://doi.org/10.1002/slct.201801151
R. Roopashree, C.D. Mohan, T.R. Swaroop, S. Jagadish and K.S. Rangappa, Asian J. Pharm. Clin. Res., 7, 309 (2014).
Y.H. Lee, S. Lee, J. Sim, E. S. Jo, J.-K. Jung, S. Hyun and J.-H. Kwak, Bull. Korean Chem. Soc., 47, 333 (2026); https://doi.org/10.1002/bkcs.70101
H.M. Poh, Y.S. Chiou, Q.Y. Chong, R.M. Chen, K.S. Rangappa, L. Ma, T. Zhu, A.P. Kumar, V. Pandey, S. Basappa, S.-C. Lee and P. Lobie, Cancers, 11, 1528 (2019); https://doi.org/10.3390/cancers11101528
M. Gilandoust, K.B. Harsha, C.D. Mohan, A.R. Raquib, S. Rangappa, V. Pandey, P.E. Lobie, Basappa and K.S. Rangappa, Bioorg. Med. Chem. Lett., 28, 2314 (2018); https://doi.org/10.1016/j.bmcl.2018.05.020
Q.Y. Chong, M.L. You, V. Pandey, A. Banerjee, Y.J. Chen, H.M. Poh, M. Zhang, L. Ma, T. Zhu, S. Basappa, L. Liu and P.E. Lobie, Oncotarget, 8, 74188 (2017); https://doi.org/10.18632/oncotarget.18431
D.S. Goodsell, M.F. Sanner, A.J. Olson and S. Forli, Protein Sci., 30, 31 (2021); https://doi.org/10.1002/pro.3934
M.D. Hanwell, D.E. Curtis, D.C. Lonie, T. Vandermeersch, E. Zurek and G.R. Hutchison, J. Cheminform., 4, 17 (2012); https://doi.org/10.1186/1758-2946-4-17
BIOVIA, Dassault Systèmes, Discovery Studio Visualizer, version 21.1.0.20298, Dassault Systèmes: San Diego, CA, USA (2020).
E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng and T.E. Ferrin, J. Comput. Chem., 25, 1605 (2004); https://doi.org/10.1002/jcc.20084